Is methylene blue legit?

What is FDA approved, and what did the oral study test?

ProvayBlue is an IV medicine approved for acquired methemoglobinemia. The compounded oral preparation offered here is not FDA approved. Approval of the IV product does not transfer to an oral prescription for focus or healthy aging.

A separate randomized trial in 26 healthy adults measured brain imaging and memory tasks one hour after a dose. Those acute findings do not establish sustained benefit from repeated use of the listed 15 mg capsule.

Read: ProvayBlue prescribing information; Rodriguez et al. Methylene blue and human brain imaging; FDA: Compounding questions and answers.

Pills, liquid or gummies: what actually changes?

AnthologyRX’s catalog lists a 15 mg capsule. Capsules state an amount per capsule; a liquid needs both its concentration and measured volume to identify the amount. A drop is not a universal dose. A gummy format does not establish approval, equivalent absorption or better safety. Compare the exact preparation and evidence for your goal, not the presentation alone.

Which medicines belong in the safety review?

The IV prescribing information warns about serious serotonin syndrome with serotonergic medicines and opioids, and hemolysis in G6PD deficiency. Include prescription drugs, supplements and over-the-counter products, including cough medicines containing dextromethorphan, in the review. The IV label is not an oral dosing or washout guide. Have the prescriber decide how interactions affect the plan rather than stopping another medicine yourself.

Read: ProvayBlue prescribing information.

Make the goal and preparation clear

Ask what condition is being treated, which formulation the supporting study used and how response will be assessed. Never substitute aquarium or industrial methylene blue for a prescribed medicine. Product grade and biological activity are separate from proof of a useful outcome.